BETABLOQUEADORES CARDIOSELECTIVOS PDF

Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our User Agreement and Privacy Policy. See our Privacy Policy and User Agreement for details. Published on Jan 29,

Author:Fenrilar Vizshura
Country:Gambia
Language:English (Spanish)
Genre:Health and Food
Published (Last):28 January 2007
Pages:315
PDF File Size:4.74 Mb
ePub File Size:16.79 Mb
ISBN:929-2-22751-737-3
Downloads:73970
Price:Free* [*Free Regsitration Required]
Uploader:Faujas



Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our User Agreement and Privacy Policy. See our Privacy Policy and User Agreement for details. Published on Jan 29, Betabloqueantes en la Insuficiencia Cardiaca. SlideShare Explore Search You. Submit Search. Successfully reported this slideshow. We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads.

You can change your ad preferences anytime. Upcoming SlideShare. Like this presentation? Why not share! Embed Size px. Start on. Show related SlideShares at end. WordPress Shortcode. CardioTeca Follow. Full Name Comment goes here. Are you sure you want to Yes No. Alejandra Molineros Arredondo. Show More. No Downloads. Views Total views. Actions Shares. Embeds 0 No embeds. No notes for slide. Betabloqueantes en la Insuficiencia Cardiaca 1. Betabloqueantes en el tratamiento de la Insuficiencia Cardiaca 2.

Aparece disnea con las actividades cotidianas. Aparece disnea con actividades de menor intensidad a las cotidianas. Aparece disnea en reposo. Rev Clin Esp ; You just clipped your first slide! Clipping is a handy way to collect important slides you want to go back to later.

Now customize the name of a clipboard to store your clips. Visibility Others can see my Clipboard. Cancel Save.

SAMBA EM PRELUDIO PDF

2005, NĂºmero 6

Hemorragia digestiva alta. Portosystemic collateral formation, particularly at the gastroesophageal junction, is a most serious consequence of portal hypertension. Increased portal pressure is the most significant force underlying gastroesophageal variceal formation, to which end portal pressure estimated from the hepatic venous pressure gradient must reach at least 10 mmHg. Subsequently, splanchnic hyperemia also contributes to variceal development. Portoystemic collaterals result from repermeabilization of pre-extant vessels, vascular remodeling, and angiogenesis. The goal of pre-primary prophylaxis is preventing or delaying the formation of gastroesophageal varices. In experimental models of portal hypertension, early administration of splanchnic vasoconstrictors such as beta-blockers, nitric oxide synthesis inhibitors, or antiangiogenic substances inhibits portosystemic collateral formation.

5L0380R DATASHEET PDF

.

Related Articles